Records 1 - 5
| Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer.
Frontiers in oncology 2022 12 957404.
Zhou Jie, Lai Yiming, Peng Shengmeng, Tang Chen, Chen Yongming, Li Lingfeng, Huang Hai, Guo Zhengh
| Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Targeted oncology 2018 Jul .
Barata Pedro C, Mendiratta Prateek, Heald Brandie, Klek Stefan, Grivas Petros, Sohal Davendra P S, Garcia Jorge
| A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Aug 23 (15): 4035-4045.
Jovanovic Bojana, Mayer Ingrid A, Mayer Erica L, Abramson Vandana G, Bardia Aditya, Sanders Melinda E, Kuba M Gabriela, Estrada Monica V, Beeler J Scott, Shaver Timothy M, Johnson Kimberly C, Sanchez Violeta, Rosenbluth Jennifer M, Dillon Patrick M, Forero-Torres Andres, Chang Jenny C, Meszoely Ingrid M, Grau Ana M, Lehmann Brian D, Shyr Yu, Sheng Quanhu, Chen Sheau-Chiann, Arteaga Carlos L, Pietenpol Jennifer
| Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients.
Clinical biochemistry 2016 Dec .
Haghgoo Seyyed Mortaza, Khosravi Adnan, Mortaz Esmaeil, Pourabdollah-Toutkaboni Mihan, Seifi Sharareh, Sabour Siamak, Allameh Abdolam
| Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.
Clinical endocrinology 2005 Jul 63 (1): 56-62.
Deeb A, Mason C, Lee Y S, Hughes I